Aethlon Medical, Inc. Stock price
Equities
AEMD
US00808Y4061
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 USD | -1.75% | +1.20% | -23.29% |
Feb. 14 | Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 14 | Transcript : Aethlon Medical, Inc., Q3 2024 Earnings Call, Feb 14, 2024 |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.4M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -13M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.32
x | P/E ratio 2025 * |
-0.48
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.39% |
Latest transcript on Aethlon Medical, Inc.
1 day | -1.75% | ||
1 week | +1.20% | ||
Current month | -2.33% | ||
1 month | -2.89% | ||
3 months | -22.94% | ||
6 months | -20.38% | ||
Current year | -23.29% |
Managers | Title | Age | Since |
---|---|---|---|
James Frakes
CEO | Chief Executive Officer | 67 | 08-01-08 |
Lee Arnold
CTO | Chief Tech/Sci/R&D Officer | 64 | - |
Guy Cipriani
COO | Chief Operating Officer | 54 | 18-06-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Frakes
CEO | Chief Executive Officer | 67 | 08-01-08 |
Chairman | 88 | 99-03-09 | |
Guy Cipriani
COO | Chief Operating Officer | 54 | 18-06-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.68 | -1.75% | 14,918 |
24-03-27 | 1.71 | -2.29% | 6,749 |
24-03-26 | 1.75 | +0.57% | 7,815 |
24-03-25 | 1.74 | +1.75% | 51,279 |
24-03-22 | 1.71 | +3.01% | 16,059 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.29% | 4.48M | |
+9.50% | 221B | |
+7.95% | 184B | |
+18.30% | 142B | |
+18.47% | 101B | |
+7.83% | 68.07B | |
+25.32% | 57.27B | |
-3.69% | 47.42B | |
+4.66% | 43.19B | |
+15.12% | 28.84B |